MilliporeSigma to become global distributor of the European Bank for induced pluripotent Stem Cells, excluding Japan Extension of relationship with Public Health England for global distribution of cost-efficient, authenticated cell lines Billerica, Massachusetts— MilliporeSigma today announced an expansion of its distribution alliance with Public Health England (PHE) to include the European Bank for induced pluripotent Stem Cells […]
Innovative method delivers simple, accurate and cost-effective SNP analysis CORALVILLE, IA – Reflecting its mission to provide innovative solutions to the genomics community, Integrated DNA Technologies (IDT) introduces its unique rhAmp™ SNP Genotyping System, enabling researchers to make accurate and confident SNP calls both quickly and cost-effectively. rhAmp technology uses a unique RNase H2/DNA polymerase two-enzyme […]
Berlin, Germany — ProBioGen AG and TissUse GmbH have signed a license and cooperation agreement to integrate ProBioGen’s Human Artificial Lymph Node Model into the Multi-Organ-Chip technology of TissUse. With the Lymph Node Model direct effects of substances on the human immune system can be monitored. The Multi-Organ-Chip technology emulates multiple interacting human organs on a […]
SAN DIEGO, CA. — June 15, 2017— Molecular Assemblies Inc., a company developing a proprietary enzymatic DNA synthesis technology, today announced that it has expanded its board of directors with the appointment of Sean Freeman, NuVasive head of strategy and corporate development, to its board of directors. “Sean’s extensive business development experience in both strategic […]
SAN FRANCISCO, Calif. – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, and the BioBricks Foundation today announced a groundbreaking agreement to provide 10,000 genes to the synthetic biology community. Under the terms of the agreement, the BioBricks Foundation (BBF) will pay for synthesis of 10,000 genes from Twist Bioscience. […]
ACEA Biosciences Announces Successful Completion of Phase I Clinical Study of Novel Autoimmune Disease Drug San Diego, CA ACEA Biosciences today announced the completion of its Phase 1 clinical study of AC0058, a novel irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor, which is in development for the treatment of B cell-related autoimmune diseases, including rheumatoid arthritis […]
BERGISCH GLADBACH – The new MACSprep™ PBMC Isolation Kit, human from Miltenyi Biotec allows the preparation of highly pure peripheral blood mononuclear cells (PBMCs) from human whole blood without density gradient centrifugation in only 25 min. The kit is ideal for the processing of small blood samples. Miltenyi Biotec has developed the MACSprep PBMC Isolation Kit, […]
Patent covers successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR Similar patents pending in other countries; anticipate favorable outcomes Billerica, Massachusetts — MilliporeSigma today announced that the Australian Patent Office has granted the company patent rights relating to the use of CRISPR in a genomic integration method for eukaryotic cells. The […]
Diagenode’s new agreement with the CeMM Research Center of Molecular Medicine of the Austrian Academy of Sciences will enable ChIP-sequencing from low input and difficult samples Denville, NJ, USA Liège, Belgium – Diagenode, a leading global provider for complete solutions for sample preparation and epigenetics research, has licensed a new technology specific for ChIP-sequencing from […]
Platform comprises Horizon’s viral, nuclease and transposon gene editing technologies for research and development Three new contract wins contributing a value of more than $2 million in 2017 with potential for long-term alliance development Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), the world leader in the application of gene editing […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

